🔗 Visit the ClinicalTrials.gov page for NCT00834665
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma. | Blood | 2010 | 1.23 |
| 2 | Trial Watch: Adoptive cell transfer immunotherapy. | Oncoimmunology | 2012 | 1.18 |
| 3 | Trial watch: Peptide vaccines in cancer therapy. | Oncoimmunology | 2012 | 1.17 |
| 4 | Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma. | Bone Marrow Transplant | 2015 | 0.89 |
| 5 | Telomere and Telomerase Therapeutics in Cancer. | Genes (Basel) | 2016 | 0.81 |
| 6 | The Role of Immunotherapy in Multiple Myeloma. | Pharmaceuticals (Basel) | 2016 | 0.77 |
| 7 | The twisted survivin connection to angiogenesis. | Mol Cancer | 2015 | 0.76 |